首页 | 本学科首页   官方微博 | 高级检索  
检索        

沈阳市MSM参加HIV暴露前预防性用药临床试验的接受意愿调查
引用本文:毛翔,于欢,胡清海,张晶,楚振兴,王亚男,耿文清,姜拥军,徐俊杰.沈阳市MSM参加HIV暴露前预防性用药临床试验的接受意愿调查[J].中华流行病学杂志,2017,38(8):1083-1087.
作者姓名:毛翔  于欢  胡清海  张晶  楚振兴  王亚男  耿文清  姜拥军  徐俊杰
作者单位:110001 沈阳, 中国医科大学附属第一医院检验科 国家卫生和计划生育委员会艾滋病免疫学重点实验室,110001 沈阳, 中国医科大学附属第一医院检验科 国家卫生和计划生育委员会艾滋病免疫学重点实验室,110001 沈阳, 中国医科大学附属第一医院检验科 国家卫生和计划生育委员会艾滋病免疫学重点实验室,110001 沈阳, 中国医科大学附属第一医院检验科 国家卫生和计划生育委员会艾滋病免疫学重点实验室,110001 沈阳, 中国医科大学附属第一医院检验科 国家卫生和计划生育委员会艾滋病免疫学重点实验室,110001 沈阳, 中国医科大学附属第一医院检验科 国家卫生和计划生育委员会艾滋病免疫学重点实验室,110001 沈阳, 中国医科大学附属第一医院检验科 国家卫生和计划生育委员会艾滋病免疫学重点实验室,110001 沈阳, 中国医科大学附属第一医院检验科 国家卫生和计划生育委员会艾滋病免疫学重点实验室,110001 沈阳, 中国医科大学附属第一医院检验科 国家卫生和计划生育委员会艾滋病免疫学重点实验室
基金项目:国家科技重大专项(2012ZX10001006);辽宁省教育厅重点实验室项目(LZ2014038);中国医科大学附属第一医院科技基金(FSFH1512)
摘    要:目的 探讨沈阳市MSM对事件驱动型(在性行为的前后特定时点)暴露前预防性用药(PrEP)预防HIV感染的接受意愿及其相关因素。方法 采用非概率抽样方法招募MSM研究对象,通过访谈式问卷调查获取社会背景学和性行为特征信息、PrEP知晓度、对特鲁瓦达(Truvada)不同服药方式的接受意愿,采用多因素logistic回归分析不同服药方式的相关因素。结果 292名MSM参加调查,PrEP知晓率为34.2%,接受事件驱动型服药方案的58.2%(170/292)高于接受日服型(每日定时)服药方案的48.3%(141/292)(χ2=5.785,P=0.02)。半年内男性性伴数>2人(aOR=1.7,95%CI:1.1~2.7)、关心药物有效性(aOR=6.4,95%CI:2.2~18.9)是接受两种服药方式共有的相关因素。存在HIV阳性性伴(aOR=8.1,95%CI:1.0~63.3)、自评HIV中高感染风险(aOR=2.6,95%CI:1.2~6.0)是接受事件驱动型服药方案独有的相关因素。结论 事件驱动型服药方案相比于日服型更易被MSM群体接受。对无法坚持每日服药、自身具有HIV危险感知意识的MSM建议推荐事件驱动型方案。

关 键 词:男男性行为者  暴露前预防性用药  接受意愿  事件驱动型服药方式
收稿时间:2016/11/30 0:00:00

Acceptability of pre-exposure HIV prophylaxis clinical trial among MSM in Shenyang city
Mao Xiang,Yu Huan,Hu Qinghai,Zhang Jing,Chu Zhenxing,Wang Yanan,Geng Wenqing,Jiang Yongjun and Xu Junjie.Acceptability of pre-exposure HIV prophylaxis clinical trial among MSM in Shenyang city[J].Chinese Journal of Epidemiology,2017,38(8):1083-1087.
Authors:Mao Xiang  Yu Huan  Hu Qinghai  Zhang Jing  Chu Zhenxing  Wang Yanan  Geng Wenqing  Jiang Yongjun and Xu Junjie
Institution:Key Laboratory of AIDS Immunology of National Health and Family Planning Commission, Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China,Key Laboratory of AIDS Immunology of National Health and Family Planning Commission, Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China,Key Laboratory of AIDS Immunology of National Health and Family Planning Commission, Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China,Key Laboratory of AIDS Immunology of National Health and Family Planning Commission, Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China,Key Laboratory of AIDS Immunology of National Health and Family Planning Commission, Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China,Key Laboratory of AIDS Immunology of National Health and Family Planning Commission, Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China,Key Laboratory of AIDS Immunology of National Health and Family Planning Commission, Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China,Key Laboratory of AIDS Immunology of National Health and Family Planning Commission, Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China and Key Laboratory of AIDS Immunology of National Health and Family Planning Commission, Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China
Abstract:
Keywords:Men who have sex with men  Pre-exposure prophylaxis  Acceptability  On-demand basis
点击此处可从《中华流行病学杂志》浏览原始摘要信息
点击此处可从《中华流行病学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号